CL
ELV icon

Choreo LLC’s Elevance Health ELV Stock Holding History

Choreo LLC’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.13M Buy
5,514
+341
+7% +$126K 0.02% 402
2026
Q1 		$1.51M Sell
5,173
-279
-5% -$91.7K 0.02% 480
2025
Q4 		$1.9M Buy
5,452
+1,107
+25% +$374K 0.02% 390
2025
Q3 		$1.4M Sell
4,345
-518
-11% -$161K 0.02% 477
2025
Q2 		$1.89M Buy
4,863
+610
+14% +$245K 0.03% 382
2025
Q1 		$1.85M Buy
4,253
+259
+6% +$104K 0.03% 353
2024
Q4 		$1.47M Sell
3,994
-1,820
-31% -$762K 0.02% 441
2024
Q3 		$2.97M Buy
5,814
+630
+12% +$337K 0.04% 274
2024
Q2 		$2.77M Buy
5,184
+3,964
+325% +$2.1M 0.05% 257
2024
Q1 		$633K Sell
1,220
-22
-2% -$10.9K 0.02% 381
2023
Q4 		$586K Buy
+1,242
New +$574K 0.02% 363
2023
Q2 		– Sell
-1,251
Closed -$575K – 477
2023
Q1 		$575K Sell
1,251
-81
-6% -$38.5K 0.02% 270
2022
Q4 		$635K Buy
+1,332
New +$676K 0.03% 130

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Choreo LLC's ELV Position: Q2 2026 in Review

Choreo LLC increased its Elevance Health (ELV) stake by 6.6% in Q2 2026, buying an estimated $126K and bringing the position to 5,514 shares worth $2.13M. The position accounts for 0.02% of the portfolio, ranked #402.

Choreo LLC first reported a position in ELV in Q4 2022 and has held it in 13 quarters since. The position peaked at $2.97M in Q3 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Choreo LLC held 5,514 shares of Elevance Health worth $2.13M as of Q2 2026.
  • Choreo LLC bought 341 Elevance Health shares in Q2 2026, an estimated $126K.
  • Elevance Health made up 0.02% of Choreo LLC's portfolio in Q2 2026, its #402 holding.
  • Choreo LLC first reported a position in Elevance Health in Q4 2022 and has held it in 13 quarters since.
  • Choreo LLC's Elevance Health position peaked at $2.97M in Q3 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.